Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong · Delayed Price · Currency is HKD 201.80
+0.20 (0.10%)
Sep 30, 2026, 4:08 PM HKT
Duality Biotherapeutics Market Cap
Duality Biotherapeutics has a market cap or net worth of 18.27 billion as of September 29, 2026. Its market cap has decreased by -42.03% in one year.
Market Cap
18.27B
Enterprise Value
15.20B
Revenue
972.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
201.80
ChartMarket Cap Chart
Since April 15, 2025, Duality Biotherapeutics's market cap has increased from 17.51B to 18.27B, an increase of 4.32%. That is a compound annual growth rate of 2.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 18.27B | -31.47% |
| Dec 31, 2025 | 26.66B | 52.24% |
| Apr 15, 2025 | 17.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| InSilico Medicine Cayman TopCo | 32.05B |
| Shanghai Henlius Biotech | 31.19B |
| InnoCare Pharma | 29.94B |
| Keymed Biosciences | 22.08B |
| Zai Lab | 22.00B |
| Metis TechBio | 18.46B |
| HBM Holdings | 11.38B |
| GenFleet Therapeutics (Shanghai) | 11.07B |